Biopharmaceutical Analysis

Articles

LGM Pharma will offer contract analytical testing and stability services to pharmaceutical developers and manufacturers.

LGM Pharma Launches Analytical Services for Drug Developers and Manufacturers

Catherine Liloia, Catherine.Liloia@ppd.com, is director at PPD Laboratories’ GMP cell lab.

Benjamin Ziehr, PhD, is senior group leader at PPD Laboratories’ GMP cell lab.

Derrick McVicker, PhD, is group leader at PPD Laboratories’ GMP cell lab.

Yat Yee Wong, PhD, is group leader at PPD Laboratories’ GMP cell lab.

Esteban Carrillo, PhD, is senior research scientist at PPD Laboratories’ GMP cell lab.

Alexander Rodriguez, PhD, is research scientist at PPD Laboratories’ GMP cell lab.

The increased number of regulatory filings for cell and gene therapies requires reevaluation of bioassay methods because of their complexity.

Development Strategies for Cell and Gene Therapy Methods

Editor of Pharmaceutical Technology Europe

Outsourcing method development offers multiple benefits to companies, including access to experience and expertise, streamlined costs, and development time efficiencies.

Developing a Method for Success through Partnerships

Feliza Mirasol is the science editor for 

The expected growth of the global bio/pharmaceutical market is pushing for the continued evolution of the CDMO arena.

CDMO Landscape Seeing Changes as Consolidation Continues

Laurent Lafferrère, PhD, is chief operating officer at PathoQuest.

Audrey Brussel, PhD, audrey.brussel@pathoquest.com, is Viral Safety leader at PathoQuest.

Assessing biosafety using NGS-based tests requires a continuum of skills in molecular biology, biocomputing, virology, and quality systems.

Challenges When Outsourcing Viral Safety Services

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Mass spectrometry and automation are growing in importance for protein characterization, but further improvements are still needed.

Evolving Analytical Technology Unravels Protein Characteristics

Shannon Parisotto, MBA, is the corporate senior vice president of Charles River Laboratories.

Accelerated drug development timelines must accommodate all crucial elements of nonclinical safety studies.  

Toxicology: Ensuring Drugs are Safe for People

The acquisition strategically expands SPT Labtech’s offering in sample management for life sciences.

SPT Labtech Strengthens Automation Services with BioMicroLab Acquisition

PathoQuest will apply its experience in viral safety testing and quality control of biologics for mitigating the risk of adventitious agent contamination in biopharmaceutical manufacturing.

PathoQuest Joins CAACB Consortium as Viral Safety Expert

The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.

Contract Analytical Services